$IRLA Income Statement | Understand Stock

$IRLA

$32.96 +$0.48 (1.48%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
Research and development
General and administrative
Goodwill impairment charge
Intangible asset impairment charge
Fair value adjustment for contingent consideration
Total operating expenses
Loss from operations
Fair value adjustment for long-term debt
Fair value adjustment for debt
Fair value adjustment for warrants
Warrant issuance costs
Interest income
Other income (expense), net
Net loss before income tax expense
Income tax expense
Net loss
Other comprehensive loss:
Foreign currency translation adjustments
Unrealized gain (loss) on available-for-sale securities
Total comprehensive loss
Net loss per share - basic and diluted
Weighted average shares of common stock outstanding - basic and diluted
Net loss per share - basic (in USD per share)
Net loss per share - diluted (in USD per share)
Weighted average shares of common stock outstanding - basic (in shares)
Weighted average shares of common stock outstanding - diluted (in shares)

Comments